Aeon Biopharma Inc (AEON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,243 | 3,006 | 5,927 | 8,439 | 10,446 |
| TOTAL | $6,625 | $3,398 | $7,412 | $10,262 | $12,321 |
| Non-Current Assets | |||||
| PPE Net | 142 | 162 | 181 | 200 | 220 |
| Other Non-Current Assets | 1,863 | 2,000 | 1,141 | 1,200 | 1,258 |
| TOTAL | $2,005 | $2,162 | $1,322 | $1,400 | $1,478 |
| Total Assets | $8,630 | $5,560 | $8,734 | $11,662 | $13,799 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,481 | 942 | 2,525 | 3,907 | 2,437 |
| Accrued Expenses | 3,005 | 4,298 | 3,071 | 2,221 | 3,444 |
| Other current liabilities | 2,183 | 1,657 | 2,632 | 3,001 | 2,759 |
| TOTAL | $6,669 | $6,897 | $8,228 | $9,129 | $8,640 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 18,713 | 53,690 | 20,378 | 18,385 | 16,482 |
| TOTAL | $18,713 | $53,690 | $20,378 | $18,385 | $16,482 |
| Total Liabilities | $25,382 | $60,587 | $28,606 | $27,514 | $25,122 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,307 | 25,303 | 11,838 | 11,644 | 11,305 |
| Common Shares | 10 | 9 | 9 | 9 | 9 |
| Retained earnings | -482,612 | -470,819 | -433,682 | -429,144 | -422,502 |
| TOTAL | $-16,752 | $-55,027 | $-19,872 | $-15,852 | $-11,323 |
| Total Liabilities And Equity | $8,630 | $5,560 | $8,734 | $11,662 | $13,799 |